Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs Vistra Corp (VST) Price & Performance

Vistra CorpTrade

Price performance (Past 24H)

Key statistics

Sanofi SA vs Vistra Corp — how do they compare? Sanofi SA trades at $40.07 (market cap $95.18B), while Vistra Corp trades at $161.48 (market cap $52.41B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Vistra Corp for 32 Days on average.

SNYVST
Market Cap
$95.18B$52.41B
Volume
2,995,64611,278,074
Sector
HealthUtilities
52-Week High
$52.34$210.85
52-Week Low
$39.51$134.71
Typical Hold Time
94 Days32 Days
Enterprise Value
$114.48B$74.34B
Dividend Yield
6.01%0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Sanofi SA

Sanofi (SNY) trades at $40.23, showing minimal daily movement with a 0.07% gain. The stock presents mixed signals with bearish technical indicators but strong fundamental performance, including three consecutive quarterly earnings beats. Recent expansion of the immunology alliance with Regeneron through an $8 billion deal highlights strategic growth initiatives. Valuation metrics show a P/E of 22.14 and P/S of 1.77, while profitability remains solid with a 72.77% gross margin.

SNY offers steady growth potential driven by pipeline expansion and Dupixent momentum, though patent expiration risks loom. Analyst sentiment is cautiously optimistic with 44% buy ratings, but technical weakness and projected 2026 earnings decline present near-term headwinds. The stock represents a balanced opportunity for long-term investors seeking pharmaceutical exposure with manageable risk.

Vistra Corp

Vistra Corp. (VST) trades at $156.14, down 6.35% on the day, with a mixed earnings history including a recent Q1 2026 beat but Q4 2025 and Q2 2026 misses. The stock shows strong profitability with an 11.55% net income margin and 75.73% ROE, while technical indicators signal a bullish trend with support at $152 and resistance at $164. Recent news highlights a $4.2 billion US loan for nuclear power expansion and a 20-year power deal with New Era Energy, positioning Vistra to capitalize on AI-driven electricity demand.

Vistra's outlook is positive, driven by nuclear power expansion and data center energy contracts, with a consensus price target of $215.23 implying 38% upside. Risks include earnings volatility, high debt levels, and regulatory uncertainties, but strong analyst support (91.3% buy ratings) and institutional interest from investors like Peter Thiel underscore growth potential in the AI power infrastructure sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SNY
35% Buy65% Sell
Avg holding period · 94 Days
VST
49% Buy51% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY →

About Vistra Corp

Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.

Read more on VST →